secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0000320017-23-000031
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lisata shareholders re-elect two Class I directors, approve equity plan amendments
--------------------------------------------------------------------------------

- Re-elected Cynthia L. Flowers and Erkki Ruoslahti as Class I directors to 2026 term; 3.76M and 3.77M votes for respectively.
- Approved amendment to 2018 Equity Incentive Plan adding 400,000 shares; 3.53M for.
- Approved amendment to 2017 ESPP increasing shares to 68,333; 3.76M for.
- Ratified Grant Thornton as independent auditor for FY2023; 5.68M for.
- Non-binding advisory approval of executive compensation; 3.71M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001723000031/0000320017-23-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001723000031/clbs-20230614.htm
  HTML page:      https://secwatch.observer/filing/0000320017-23-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer